AUERBACH ALAN H 4
4 · PUMA BIOTECHNOLOGY, INC. · Filed Mar 19, 2024
Insider Transaction Report
Form 4
AUERBACH ALAN H
DirectorPresident and CEO10% Owner
Transactions
- Award
Common Stock
2024-03-15+6,577→ 7,104,320 total - Award
Stock Option (Right to Buy)
2024-03-15+9,047→ 9,047 totalExercise: $5.00Exp: 2034-03-14→ Common Stock (9,047 underlying)
Footnotes (3)
- [F1]Reflects supplemental annual equity awards due to an administrative error in the calculations used to determine the original number of shares underlying the annual equity awards.
- [F2]Subject to Grantee's continued status as an Employee of the Company, the Restricted Stock Units ("RSUs") shall vest with respect to one-fourth (1/4th) of the RSUs on each of July 1, 2024, January 1, 2025, July 1, 2025 and January 1, 2026, subject to acceleration in certain events.
- [F3]Subject to Optionee's continued status as an Employee of the Company, Options shall vest and become exercisable with respect to one-fourth (1/4th) of the Shares subject thereto on each of July 1, 2024, January 1, 2025, July 1, 2025 and January 1, 2026, subject to acceleration in certain events.